BRISBANE, Calif., Aug. 08, 2025 - Vera Therapeutics, Inc. (Nasdaq: VERA) has disclosed the granting of inducement awards to eight new employees under its 2024 Inducement Plan, as approved by the company's Compensation Committee. On August 4, 2025, the awarded inducements included non-qualified stock options to purchase 99,000 shares of Class A common stock and restricted stock units (RSUs) for 48,200 shares. The stock options carry an exercise price of $20.45 per share, matching the closing trading price on the grant date, and will vest over four years. RSUs are set to vest annually over the same period, beginning on August 20, 2025. These awards are in accordance with Nasdaq Listing Rule 5635(c)(4), contingent on continued employment with Vera.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.